Article Text

PDF

Audit, research and guideline update
Uptake of neonatal BCG vaccination in England: performance of the current policy recommendations
  1. Patrick Nguipdop-Djomo1,2,
  2. Punam Mangtani1,
  3. Debora Pedrazzoli1,2,
  4. Laura C Rodrigues1,
  5. Ibrahim Abubakar2,3
  1. 1TB Centre and Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK
  2. 2Respiratory Diseases Department, Public Health England, London, UK
  3. 3Research Department of Infection and Population Health, University College of London, London, UK
  1. Correspondence to Dr Patrick Nguipdop-Djomo, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK; patrick.nguipdop-djomo{at}lshtm.ac.uk

Abstract

BCG uptake among infants in England has not been measured since targeted infant vaccination replaced universal schoolchildren vaccination in 2005, mainly because of the challenges in defining denominators. We estimated uptake between 2006 and 2008 by dividing number of BCG doses administered to infants by number of all live births (where BCG vaccination is universal) or ethnic minority/Eastern Europeans live births (where infant-BCG vaccination is selective). Weighted average uptake was 68% (95% CI 65% to 71%), slightly higher in primary care trusts with universal (72% (95% CI 64% to 80%)) than selective (66% (95% CI 61% to 70%)) policy; and also 13% higher in areas vaccinating in postnatal wards compared with community settings.

  • Tuberculosis

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.